Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
Pharmacokinetic Evaluation of Serum Testosterone Concentrations After Administration of Clomiphene Citrate

This is a randomized, open-label trial examining two doses of clomiphene citrate in men with low serum testosterone concentrations (total testosterone (TT) < 300 ng/dl).

Accepts healthy volunteers
  • 0 views
  • 09 Jun, 2022
  • 1 location
FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea (FRIEND)

The objective of this study is to determine the effect of low caffeine green tea extract containing 45% epigallocatechin gallate (EGCG) on fibroids and subsequent pregnancy and live births in women seeking fertility treatment. The population will consist of 200 women desirous of conceiving, ages ≥18 to ≤40 years (at …

hysteroscopy
  • 0 views
  • 07 Oct, 2022
  • 3 locations
Letrozole in Stimulated IVF Cycles

cancer because of its action to reduce the intra-ovarian aromatization of androgens to estrogens. It is now increasingly used for ovulation induction and is as safe as clomiphene citrate. Use of

cancer
in vitro fertilization
antral
clomiphene
ovarian stimulation
  • 395 views
  • 19 Apr, 2022
  • 2 locations
Letrozole Versus Laparoscopic Ovarian Drilling in Polycystic Ovary Syndrome

Polycystic ovary syndrome is the major cause of anovulatory infertility. Clomiphene citrate is the most commonly used oral agent for ovulation induction in this group, but there are some

letrozole
clomiphene
anovulatory
polycystic ovary syndrome
semen analysis
  • 200 views
  • 30 May, 2022
  • 1 location
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation (CLC II)

This study evaluates the addition of clomiphene citrate (CC) to letrozole for the treatment of infertility in women with polycystic ovary syndrome across a course of two treatment cycles with

infertility
clomiphene
anovulatory
oligomenorrhea
clomid
  • 20 views
  • 24 Mar, 2022
  • 1 location
Prospective, Randomized Trial Comparing Luteal Phase Ovarian Stimulation, and Luteal Estradiol Priming Protocol for Patients With Diminished Ovarian Reserve - The LUTEAL Trial

Ovarian reserve defines the quantity and quality of the ovarian primordial follicular pool. Diminished ovarian reserve (DOR) indicates a reduction in the quantity of ovarian follicular pool to less than expected for age. It is an important cause of infertility in many couples. To date, there is no clear consensus …

in vitro fertilization
antral
infertility
reproductive technology
assisted reproductive technology
  • 598 views
  • 28 Oct, 2022
  • 1 location
INTEnsity of ovariaN Stimulation and Embryo Quality (INTENS-EQ)

The management of suboptimal ovarian responders remains a challenging task in IVF. These patients are frequently managed with an intense stimulation protocol of ovarian stimulation in order obtain the maximum number of embryos and, therefore, maximize the cumulative live birth rate. However, the concept of "the more the better" has …

antral
mullerian inhibiting substance
anti-mullerian hormone
ovarian stimulation
gonadotropin
  • 26 views
  • 24 Mar, 2022
  • 1 location
Follicular FSH Serum Level as a Predictor of an Oocyte Quality and Yield in Fertility Preservation Cycles for Women With a Compromised Ovarian Reserve.

coverage entitlement is elevated day 3 FSH level. The tests used for assessing ovarian reserve include basal day -3 follicle stimulating hormone (FSH, introduced in 1998). Clomiphene citrate

antral
clomiphene
assisted reproductive technology
mullerian inhibiting substance
anti-mullerian hormone
  • 0 views
  • 24 Oct, 2022
  • 1 location